Evidence map›Paper›PMID 35103548›Full record

ArticleHuman vaccines & immunotherapeutics2022

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.

Weerawan Hattasingh, Pornthep Chanthavanich, Chukiat Sirivichayakul, Watcharee Arunsodsai, Surachai Surangsrirat, Termsang Srisuwannaporn, Benjawan Kaewma, Sutee Yoksan, Kriengsak Limkittikul, Junwei Yang and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Weerawan HattasinghDepartment of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Pornthep ChanthavanichDepartment of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Chukiat SirivichayakulDepartment of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Watcharee ArunsodsaiDepartment of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Surachai SurangsriratNopparat Rajathanee Hospital, Ministry of Public Health, Bangkok, Thailand.
Termsang SrisuwannapornNopparat Rajathanee Hospital, Ministry of Public Health, Bangkok, Thailand.
Benjawan KaewmaNopparat Rajathanee Hospital, Ministry of Public Health, Bangkok, Thailand.
Sutee YoksanJapanese Encephalitis/Dengue Virology Laboratory, Center for Vaccine Development, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
Kriengsak LimkittikulDepartment of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Junwei YangLiaoning Cheng Da Biotechnology Co., Ltd., Shenyang, China.ORCID 0000-0003-1450-0156
Yu MaoLiaoning Cheng Da Biotechnology Co., Ltd., Shenyang, China.ORCID 0000-0002-1437-5730
Mahidol University · THMinistry of Public Health · THGDL (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japanese encephalitis is the main cause of viral encephalitis in Asia. In a previous single-arm vaccine trial, an inactivated chromatographically purified Japanese encephalitis Vero cell vaccine (CVI-JE; JEVAC

Indexed as

Encephalitis, JapaneseJapanese Encephalitis VaccinesAnimalsAntibodies, ViralAntigens, ViralChildChlorocebus aethiopsHumansThailandVero CellsAntibodies, ViralAntigens, ViralJapanese Encephalitis VaccinesChildrenchromatographical purifyimmunogenicityinactivated Vero cell-derived vaccineJapanese encephalitis vaccinelong-term follow-up

Identifiers

PMID35103548
PMCPMC8993053
OpenAlexW4210379960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.